StriVectin Operating Company, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
StriVectin Operating Company, Inc. - overview
Established
2002
Location
New York, NY, US
Primary Industry
Consumer Products
About
StriVectin Operating Company, based in the US, is a skincare company specializing in innovative products designed to combat visible signs of aging, ensuring effective solutions for a diverse customer base. Founded in 2002 and headquartered in New York, US, StriVectin Operating Company, Inc. focuses on developing advanced skincare solutions. The company has undergone a strategic acquisition by Crown Laboratories, Inc.
in August 2021, enhancing its growth potential and resource access. Joan Malloy serves as the CEO, leading the company through its expansion. The firm has completed a total of 3 deals, with the most recent deal occurring on 2021-08-26. StriVectin specializes in skincare products targeting visible signs of aging, including fine lines, wrinkles, and loss of firmness.
Key offerings include TL Advanced™ Tightening Neck Cream PLUS, Peptight™ Face Lift Serum, and Peptide Plump™ Collagen Cushion Cream, utilizing proprietary technologies like NIA-114™ and peptides. The products cater to a wide range of customers seeking effective anti-aging solutions, marketed primarily in North America, with an expanding presence in Europe and Asia, emphasizing direct-to-consumer sales through its website and retailer partnerships. StriVectin generates revenue through direct sales and retail partnerships, implementing a multi-channel sales approach. Flagship products are priced at USD 99 for TL Advanced™ Tightening Neck Cream PLUS and USD 89 for Peptight™ Face Lift Serum.
The company employs promotional strategies, such as a 15% discount for first-time buyers, and a loyalty program to encourage repeat purchases, contributing to its premium positioning within the skincare market. Following the acquisition by Crown Laboratories, Inc. in August 2021, StriVectin aims to accelerate growth across all product areas by utilizing additional resources. The company plans to introduce new products and strengthen its infrastructure to deliver skincare solutions to a broader audience.
Targeted expansion includes entering international markets in Europe and Asia by mid-2023, enhancing its global footprint and product development capabilities.
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.strivectin.com
Verticals
E-commerce, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
StriVectin Operating Company, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Announced | StriVectin Operating Company, Inc. | - | ||||||||
| Buyout | Completed | StriVectin Operating Company, Inc. | - | ||||||||
| Private Debt | Completed | StriVectin Operating Company, Inc. | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.